Post
Genmab/AbbVie report results for epcoritamab development program
Genmab reported positive Phase I/II data for its bispecific antibody, which was developed in collaboration with AbbVie at the European …
Ryvu’s small molecule cancer therapies report positive clinical results
Ryvu Therapeutics reported safety and efficacy data from the Phase Ib dose-escalation study of RVU120 in patients with acute myeloid …
MediPrint’s drug-releasing contact lens reduces intraocular pressure in glaucoma patients
MediPrint Ophthalmics has unveiled interim results from a study showing its drug releasing contact lens can reduce intraocular pressure (IOP) …
Leading e-consent providers for clinical research
The landscape of clinical trials is rapidly evolving with the advent of digital transformation. One of the key innovations revolutionising …
PaxMedica and PoloMar to investigate emodin in ASD trial
PaxMedica has entered a research collaboration agreement with PoloMar Health to investigate the use of the anti-purinergic compound emodin in …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Cingulate completes Phase III trial of ADHD therapy in adults
Cingulate has completed the Phase III trial of its lead candidate CTx-1301 (dexmethylphenidate) for the treatment of attention-deficit/hyperactivity disorder (ADHD) …
Metformin could reduce long Covid rates, large study finds
The anti-diabetic drug metformin, when taken at the time of Covid-19 infection, could reduce the rate of long Covid-19, a …
Gonorrhoea infections in the UK reach an all-time high
During 2020 and 2021, the UK Health Security Agency reported that diagnoses of sexually transmitted infections (STIs) decreased significantly, which …
Annovis Bio completes patient enrolment in study of Parkinson’s drug
Annovis Bio has completed the enrolment of patients in a record nine months from the initiation of its Phase III …
FDA clears EpimAb’s IND for trial of cancer combo therapy
The US Food and Drug Administration (FDA) has granted clearance to EpimAb Biotherapeutics’ investigational new drug (IND) application enabling initiation …
The challenges of clinical data management: Can consent management software help?
Clinical data management (CDM) is one of the most critical aspects of clinical research. Trial data must be accurate to …
LianBio concludes subject enrolment in Phase III TP-03 trial in China
LianBio has completed enrolment in the Phase III LIBRA clinical trial of TP-03 (lotilaner ophthalmic solution, 0.25%) in Demodex blepharitis …
Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102
Azafaros has enrolled the first participant in its Phase II RAINBOW trial of AZ-3102 in GM2 gangliosidosis and Niemann-Pick disease …
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as …
Nexstim pilot study shows boost for depression symptoms
Nexstim has reported results from its pilot study on the use of accelerated intermittent theta burst stimulation (iTBS) protocol in …